%0 Journal Article
%9 ACL : Articles dans des revues avec comité de lecture répertoriées par l'AERES
%A Quiliano, M.
%A Mendoza, A.
%A Fong, K. Y.
%A Pabon, A.
%A Goldfarb, N. E.
%A Fabing, I.
%A Vettorazzi, A.
%A de Cerain, A. L.
%A Dunn, B. M.
%A Garavito, G.
%A Wright, D. W.
%A Deharo, Eric
%A Perez-Silanes, S.
%A Aldana, I.
%A Galiano, S.
%T Exploring the scope of new arylamino alcohol derivatives : synthesis, antimalarial evaluation, toxicological studies, and target exploration
%D 2016
%L fdi:010068947
%G ENG
%J International Journal for Parasitology-Drugs and Drug Resistance
%@ 2211-3207
%K Antimalarial ; Antiplasmodial ; Arylamino alcohol ; Plasmepsin II enzyme ; Hemozoin inhibition ; Mannich reaction
%M ISI:000393046300007
%N 3
%P 184-198
%R 10.1016/j.ijpddr.2016.09.004
%U https://www.documentation.ird.fr/hor/fdi:010068947
%> https://www.documentation.ird.fr/intranet/publi/2017/03/010068947.pdf
%V 6
%W Horizon (IRD)
%X Synthesis of new 1-aryl-3-substituted propanol derivatives followed by structure-activity relationship, in silico drug-likeness, cytotoxicity, genotoxicity, in silico metabolism, in silico pharmacophore modeling, and in vivo studies led to the identification of compounds 22 and 23 with significant in vitro anti-plasmodial activity against drug sensitive (D6 IC50 <= 0.19 mu M) and multidrug resistant (FCR-3 IC50 <= 0.40 mu M and C235 IC50 <= 0.28 mu M) strains of Plasmodium falciparum. Adequate selectivity index and absence of genotoxicity was also observed. Notably, compound 22 displays excellent parasitemia reduction (98 +/- 1%), and complete cure with all treated mice surviving through the entire period with no signs of toxicity. One important factor is the agreement between in vitro potency and in vivo studies. Target exploration was performed; this chemotype series exhibits an alternative antimalarial mechanism.
%$ 020 ; 052